The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence
|
|
- Marvin West
- 6 years ago
- Views:
Transcription
1 The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary University of London
2 Cancer, rare disease, infection Genomics England Mission Sequence 100,000 whole genomes Capture data delivered electronically, store it securely and analyse it within an English data centre (reading library) Genomes with electronic clinical information for longitudinal life course analysis, interpretation, and aggregation Transform the NHS capacity, capability and leave a legacy in personalised medicine to generate health and wealth for the UK 1. To bring benefit to NHS patients 3. To create an ethical and transparent programme based on consent 2. To enable new scientific discovery and medical insights 4. To kickstart the development of a UK genomics industry
3 The 100,000 Genomes Project 04 November
4 Genomics England The Big Data Potential 13 NHS Genomic Medicine Centres Rare diseases, cancers and pathogens Broad consent, characteristics, molecular pathology and samples NIHR Biosample Centre DNA & multi-omics Repository Sequencing Centre Wellcome Trust 27m Illumina Partnership Refreshable identifiable Clinical Data Life-course registry Linked to anonymised Whole Genome Sequence Oxford Big Data NHS Digital Primary Care Hospital episodes Cancer Registries Rare Registries Infectious Disease Mortality data Patient entry Fire wall Patient data stays in safe haven MRC 24m Research Data Infrastructure Sequential builds of pseudonymised data and WGS Safe haven- Reading library Annotation & QC SME Product comparison Only processed results pass outside Clinicians & Academics 25m in Training 700 person years Industry GENE Consortium
5 New Sequencing Centre at Hinxton US genomics giant Illumina building new European HQ in Cambridge jobs 60 M
6 Rare Inherited diseases 5000 people in the pilot 18,000 in the main programme <5% of the population 7000 rare diseases 150/200 disorders Detailed standardised eligibility & characterisation Prior genetic testing usual care Human Phenotyping Ontology Disease progression WGS 30X
7 Newborn with severe immunodeficiency Closely related parents New born in ITU from birth Recurrent infections Fluctuating neurology Unexplained lots of tests Child died at 4 months with no diagnosis Parents and deceased child join the 100,000 Genomes Project at their request Mum becomes pregnant and declines all testing but at 8 months becomes anxious Mutation identified, NHS validate it, fed back
8 Sequencing cancer genomes The diagnostic and the genomic biopsy Cancer programme Gear 1- mainstream supply of fresh frozen tissue Gear 2- small studies Gear 3- trials Cancer is challenging Transforming molecular pathology High calibre genomes Actionable 25-40% of the time Working on lung, breast, colon, prostate, ovary, sarcoma, renal, haematological oncology Adopting bladder, brain, testis, childhood cancer, unknown primary
9 Infections and Pathogens 3000 Multi-drug resistance TB strains NHS implementing TB sequencing for diagnosis Global registry of TB resistance
10 Genomics England Clinical Interpretation Partnership Matina Prapa, Simon Thompson and Kate Witowska
11 Why do we need a Clinical Interpretation Partnership? The standard way The GeCIP way Start yrs?3 yrs Securing Patient Benefit
12 Information about a patient s main condition What are we telling Information about additional serious and actionable conditions (optional) participants? Carrier status for non affected parents of children with rare disease (optional) Image courtesy of Health Education England 04 November
13 Industry Consortium and Partners 12 pharma/diagnostics/smes Precompetitive consortia Work together on 5000 WGS to shape data centre Individual company interactions Inward investment from Illumina 50m in new HQ in Cambridge AbbVie Alexion Pharmaceuticals AstraZeneca Biogen Dimension Therapeutics GSK Helomics Roche Takeda Berg Boehringer Ingelheim UCB
14 International Country Description Status Details of joint working Canada Australia Genome British Columbia/ Canada Garvan Institute Australian Genomes MoU signed MoU signed Estonia Central biobank Meeting held Denmark Norway 5 regional health sectors & central biobank National hub & spoke model Meeting held & visit undertaken Meetings held Partnership projects under consideration GMC Data Visualisation Intellectual disability Potential for national collaboration France INSERM & Genopole Meetings held 600m Euros Singapore National initiative Meeting held Some funds Japan National Initiative Multiple meetings held Circa 70m programme
15 Building the future of genomic medicine 100,000 WGS on NHS patients and pathogens Concentrating the UK Genomics Knowledgebase in one location The NHS, academics and industry partnerships at the outset to drive Genomic Medicine into the NHS and create wealth Building the human capacity and capability Key international partnerships to add value Leave a legacy of NGS Centres, sample pipeline and biorepository, large-scale data store that makes this usable by the NHS New diagnostics and therapies and opportunities for patients
16 More information and jobs =twsrc%5etfw
Genomics and personalised medicine
Genomics and personalised medicine Dr Tom Fowler, Deputy Chief Scientist & Director of Public Health WHO Symposium on the Future of Digital Health Systems in the European Region February 2019 About me
More informationThe 100,000 Genomes Project
The 100,000 Genomes Project Dr Tom Fowler, Deputy Chief Scientist Genomics England Jillian Hastings Ward, Chair, National 100K Participant Panel The Kings Fund, 6th October 2017 Our Mission 100,000 whole
More informationThe 100,000 Genomes Project Rare Disease Programme
The 100,000 Genomes Project Rare Disease Programme Dr Richard Scott Clinical Lead for Rare Disease, Genomics England Consultant in Clinical Genetics, Great Ormond Street The 100,000 Genomes Project History
More informationThe 100,000 Genomes Project
The 100,000 Genomes Project Louise J Jones Genomics England James Fisher Director, Genomics Implementation Unit North East & North Cumbria Cancer Alliance Launch Event 30 th March 2017 The first human
More informationGenomics in the NHS. Professor Sue Chief Scientific Officer for England
Genomics in the NHS Professor Sue Hill @CSOSue Chief Scientific Officer for England Nov 2017 100,000 Genomes Project: overview PRINCIPLES 100,000 genomes from Rare Disease (families) & Cancer (people &
More informationNHS ENGLAND BOARD PAPER
NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce
More informationDelivering Genomic Medicine at a Population Level: beyond the 100,000 Genomes Project
Delivering Genomic Medicine at a Population Level: beyond the 100,000 Genomes Project J Louise Jones Barts Cancer Institute Barts Health NHS Trust Genomics England What is Genomic Medicine? an emerging
More informationBOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy.
Paper: PB.24.09.15/05 Title: Personalised Medicine Strategy. From: Sir Bruce Keogh, National Medical Director. BOARD PAPER - NHS ENGLAND Purpose of Paper: To inform the Board of the development of an NHS
More informationGenomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service
Genomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service Professor Dame Sue Hill @CSOsue Chief Scientific Officer for England SRO Genomics, NHS England September 2018 Genomics:
More informationScottish Genomes Project: Taking Genomics into Healthcare. Zosia Miedzybrodzka
Scottish Genomes Project: Taking Genomics into Healthcare Zosia Miedzybrodzka DNA GENOME IS ALL OF OUR DNA: CODING & NON-CODING Sequencing of Whole Genomes at Scale in Scotland Edinburgh Genomics Sequencing
More information1.0 Background to the organisation
1.0 Background to the organisation The National University of Ireland Galway, the Royal College of Surgeons in Ireland, University College Cork, University College Dublin and Trinity College and their
More informationGenomic Strategy for Scotland. ACGS Meeting 29 th June 2018
Genomic Strategy for Scotland ACGS Meeting 29 th June 2018 The current landscape Advances in genomics and informatics are driving a better understanding of the molecular basis of disease. Rapid advancement
More informationThe NIHR. NIHR: health research in Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London. Clinical Research Network
The NIHR NIHR: health research in 2030 Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London Why? https://www.bhf.org.uk/publications/statistics/ trends-in-coronary-heart-disease-1961-2011
More informationThe NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England
The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.
More information100,000 Genomes Project Rare Disease Programme. Dr Richard Scott Clinical Lead for Rare Disease, Genomics England
100,000 Genomes Project Rare Disease Programme Dr Richard Scott Clinical Lead for Rare Disease, Genomics England Recruitment to 16 th June 31,231 rare disease participants Average = 490 participants /
More informationWhole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015
Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015 Dr. I.J. Nijman Disclosure slide (Potential) conflict of interest None For this meeting relevant
More informationInterpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI
Interpreting Genome Data for Personalised Medicine Professor Dame Janet Thornton EMBL-EBI Deciphering a genome 3 billion bases 4 million variants 21,000 coding variants 10,000 non-synonymous variants 50-100
More informationMolecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
More informationCreating a national Genomic Medicine Service. Professor Sue Chief Scientific Officer for England
Creating a national Genomic Medicine Service Professor Sue Hill @CSOsue Chief Scientific Officer for England Jun 2017 Into the next generation science moving beyond genomics alone DNA HGP 100,000 Genomes
More informationRoche in Australia Innovation Leader
Roche in Australia Innovation Leader About Roche Innovation: it s in our DNA 7,000,874 hours of work 6,587 experiments 423 researchers 1 drug For nearly 120 years, Roche has been committed to improving
More informationA whole-system approach to delivering personalised medicine and health in Leeds. Mike Messenger
A whole-system approach to delivering personalised medicine and health in Leeds Mike Messenger Capacity and Resource What is the challenge? In 2016, we face the most significant challenges for a generation.
More informationImplementing a National Genomic Medicine Service for the NHS: building on the legacy of the 100,000 Genomes Project
Implementing a National Genomic Medicine Service for the NHS: building on the legacy of the 100,000 Genomes Project A joint event by the All-Party Parliamentary Health Group and the All- Party Parliamentary
More informationPharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001
Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response
More informationIRDiRC: International Rare Diseases Research Consortium
IRDiRC: International Rare Diseases Research Consortium EuRenomics, NEUROMICS and RD-Connect Joint Kick-off Meeting Sitges, Spain, 25 January 2013 Dr. Iiro Eerola Scientific Project Officer Unit for Personalised
More information2018/2019 final draft National Genomic Test Directory FAQ
2018/2019 final draft National Genomic Test Directory FAQ August 2018 1 Contents 1 Introduction... 3 2 About the Test Directory... 3 3 Frequently asked questions... 4 3.1 Where has the Test Directory been
More informationImproving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre
Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Bryan Williams MD FRCP FESC FAHA Professor of Medicine and BRC Director 29/08/2013 Creating
More informationDelivering on the Promise of Precision Medicine
Delivering on the Promise of Precision Medicine Bay Area Council Economic Institute Spring 2016 The Promise of Precision Medicine The Bay Area is one of the world s biggest hubs for innovation in research
More informationDelivering the NIHR Central Commissioning Facility
Delivering the NIHR Central Commissioning Facility About the NIHR The National Institute for Health Research is funded through the Department of Health to improve the health and wealth of the nation through
More informationTRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS. H a n n s Lochmüller, Newcastle University
TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS H a n n s Lochmüller, Newcastle University Addressing the translational pathway 2 Trials Gene identification/ pathophysiology
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More information7/21/2017. Transforming the histopathology workforce: perspectives from the Genomics Education Programme
Transforming the histopathology workforce: perspectives from the Genomics Education Programme Dr Anneke Seller, Scientific Director, HEE Genomics Education Programme 100,000 Genomes: Cornerstone of future
More informationResearch and innovation at the heart of the NHS Sir Malcolm Grant, Chair, NHSE
Research and innovation at the heart of the NHS Sir Malcolm Grant, Chair, NHSE NHS Health and Care Innovation Expo 6 September 2018 What this session is about The economic case The opportunity: research
More informationNordic Common Strengths and Future Potential in the Field of Personalised Medicine
Nordic Common Strengths and Future Potential in the Field of Personalised Medicine NOS-M Workshop 23rd November 2016 Stockholm Waterfront Johan Nilsson Coordinator Medicine and Health Swedish Research
More informationTHE WHITE HOUSE Office of the Vice President
FOR IMMEDIATE RELEASE October 17, 2016 THE WHITE HOUSE Office of the Vice President FACT SHEET: Vice President Biden Delivers Cancer Moonshot Report, Announces Public and Private Sector Actions to Advance
More informationBiobanking for the 100,000 genomes project. BBMRI-UKCTC satellite meeting 29 th September
Biobanking for the 100,000 genomes project BBMRI-UKCTC satellite meeting 29 th September The challenge Scale Quality Patient to sample/data to clinician Impact of pre-analytical variables vs cost of process
More informationThe HUNT Study and potential for innovation and industry research collaboration
1 The HUNT Study and potential for innovation and industry research collaboration Professor Kristian Hveem, MD, PhD, Director of HUNT biobank, NTNU Head of Biobank Norway (BBMRI.no) Head of K.G. Jensen
More informationBIOMEDICAL RESEARCH CENTRES
Introduction BIOMEDICAL RESEARCH CENTRES The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the
More informationTRANSLATIONAL RESEARCH PARTNERSHIPS
TRANSLATIONAL RESEARCH PARTNERSHIPS Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. NIHR Translational Research
More informationNIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE
NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE EXPERTISE AND CAPABILITIES The TRC in Inflammatory Respiratory Disease provides cutting-edge expertise in the development of exploratory
More informationResearch and development case study. Human health research
Research and development case study Human health research November 2017 Introduction This case study on human health research is one of a series that we have developed to support and complement our published
More informationMRC Stratified Medicine Initiative
MRC Stratified Medicine Initiative Jonathan Pearce Medical Research Council, Translational Programme Manager Pharmacogenetics and Stratified Medicine Network Conference : 14 th January 2015 Stratified
More informationSupporting efficient and effective clinical research in the UK
Supporting efficient and effective clinical research in the UK National Institute for Health Research 10 years of delivering health and care research for the nation HRB CRCI Launch Dr Matthew Hallsworth
More informationData Mining for Genomic- Phenomic Correlations
Data Mining for Genomic- Phenomic Correlations Joyce C. Niland, Ph.D. Associate Director & Chair, Information Sciences Rebecca Nelson, Ph.D. Lead, Data Mining Section City of Hope National Medical Center
More informationUsing Human Tissue in Translational Research and Clinical Trials
Using Human Tissue in Translational Research and Clinical Trials Dr Bridget S Wilkins NCRI Clinical Lead for Pathology Engagement (Consultant Histopathologist, St Thomas Hospital, London) Cellular and
More informationThe Curative and Transformative Potential of Novel Therapies for Rare Diseases in the Age of Precision Medicine
The Curative and Transformative Potential of Novel Therapies for Rare Diseases in the Age of Precision Medicine Christopher P. Austin, M.D. Director, NCATS/NIH EveryLife Scientific Workshop September 12,
More informationGenomics for Precision Medicine Strategy
Genomics for Precision Medicine Strategy July 2017 Mae r ddogfen yma hefyd ar gael yn Gymraeg. This document is also available in Welsh. Crown Copyright WG 32505 Genomics for Precision Medicine Strategy
More informationUnlocking the Power of the Genome
Unlocking the Power of the Genome Sam Samad, Chief Financial Officer William Blair Growth Stock Conference, 13 June 2018 2018 Illumina, Inc. All rights reserved. Safe Harbor Statement This presentation
More informationRare Diseases: Challenges and Opportunities NIH Perspective
Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes
More informationThe Innovative Medicines Initiative. Pierre Meulien CNIO, Madrid - Spain
The Innovative Medicines Initiative Pierre Meulien 12.01.2017 CNIO, Madrid - Spain IMI Europe s partnership for health > 5 bn 2.5 bn Partnership 2008-2020 Pharma industry 2.5 bn EU contribution from FP7
More informationADVANCE MEDICINE. AstraZeneca Japan President Stefan Woxström shares his healthcare vision. By C Bryan Jones
ADVANCE MEDICINE AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With
More informationOverview: Towards a European open source knowledge management infrastructure. Scott Wagers, MD BioSci Consulting
Overview: Towards a European open source knowledge management infrastructure Scott Wagers, MD BioSci Consulting Innovative Medicines Initiative: Joining Forces in the Healthcare Sector U-BIOPRED Annual
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More informationImproved analysis of genetic testing could lead to more patients with inherited conditions being successfully diagnosed
PRESS RELEASE 17 August 2016 Improved analysis of genetic testing could lead to more patients with inherited conditions being successfully diagnosed A groundbreaking study, led by experts from Royal Brompton
More informationWhat does Big Pharma want?
Tissue banking in the NHS - the advantages for Pathology Departments What does Big Pharma want? Why do we want it? How do we get it? Chris Womack Principal Clinical Histopathologist Oncology Early Drug
More informationEU Big Data Initiatives
European Network of Excellence for Big Data in Hematology, consisting of 51 partners from 11 countries. Aliki Taylor, HARMONY Alliance Partner Director Global Health Outcomes, Takeda EU Big Data Initiatives
More informationLEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE
LEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE LEEDS CITY REGION S STRENGTHS: LIFE SCIENCES - THE OPPORTUNITY TAP INTO WORLD-LEADING RESEARCH FROM LEEDS CITY REGION S UNIVERSITIES ACCELERATING
More informationPERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS
PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS CLEAR DIAGNOSIS TARGETED TREATMENT STRENGTHENED RESEARCH SUMMARY NATIONAL STRATEGY FOR PERSONALISED MEDICINE 2017-2020 FOREWORD Personalised Medicine
More informationVision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University
Vision, aims and strategies Department of Immunology, Genetics and Pathology Uppsala University April19,2011 SCOPEOFACTIVITIESATIGP Research at the Department focuses on translational medicine through
More informationClinical Trial Research in the Precision Medicine Era: the Manchester City Approach
1 Clinical Trial Research in the Precision Medicine Era: the Manchester City Approach JACK LONDON, PHD RESEARCH PROFESSOR OF CANCER BIOLOGY THOMAS JEFFERSON UNIVERSITY DIRECTOR OF INFORMATICS SIDNEY KIMMEL
More informationPHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14
PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 Submitted resources from physician organization representatives were mapped
More information- OMICS IN PERSONALISED MEDICINE
SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary
More informationROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure
ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure Marialuisa Lavitrano Università Milano-Bicocca Coordinatore BBMRI-Italia
More informationEthics of Precision Medicine in Low to Middle Income Countries
Ethics of Precision Medicine in Low to Middle Income Countries Sola Olopade, MD, MPH Professor of Medicine Director, International Programs Faculty, MacLean Center for Clinical Ethics University of Chicago
More informationChristoph Bock ICPerMed First Research Workshop Milano, 26 June 2017
New Tools for Personalized Medicine *Tools = Assays, Devices, Software Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017 http://epigenomics.cemm.oeaw.ac.at http://biomedical-sequencing.at
More informationUniversity of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine
University of Athens - Medical School pmedgr The Greek Research Infrastructure for Personalized Medicine - George Kollias - Professor of Experimental Physiology, Medical School, University of Athens President
More informationThe Innovative Medicines Initiative: Building new models of collaborative research across Europe
The Innovative Medicines Initiative: Building new models of collaborative research across Europe Elisabetta Vaudano IMI, Belgium www.imi.europa.eu What is IMI? An European Public-Private Partnership Focused
More informationTranslational Research
Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic
More informationInterview. Maximizing the Value of Biospecimens to Deliver New Therapies. with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca
Interview Maximizing the Value of Biospecimens to Deliver New Therapies with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca Introduction and Background CLIVE GREEN This ebook originated
More informationYour genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health
Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap
More informationStratified Medicine in the UK
Technology Strategy Board Driving Innovation Stratified Medicine in the UK Vision and Roadmap Stratified Medicine in the UK Stratified Medicine in the UK Vision and Roadmap Summary A consortium of government
More informationGenomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC
Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results
More informationInnovative Medicines Initiative
Innovative Medicines Initiative EMA - EBE Regulatory Conference on ATMPs Salah-Dine Chibout, Novartis Global Head Discovery & Investigative Safety/ Global Head Preclinical Safety Therapeutic Areas IMI
More informationNIHR Cambridge Clinical Research Facility
NIHR Cambridge Clinical Research Facility National Institute for Health Research The perfect environment for experimental medicine studies and early phase clinical trials for Life Sciences, Biotech and
More informationPresented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego
Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you
More informationGUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS
GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS 1. Introduction 1.1 This document provides guidance notes for the assessment of academic qualifications that have not been formally accredited
More informationFinnish Biobanks. The most advanced testbed in the world
Finnish Biobanks The most advanced testbed in the world Jaana Hartikainen, Ph.D., Adjunct Professor in Molecular Genetics Assistant Professor in Translational Cancer Research and Biobank Research University
More informationGenomics and Healthcare A global and local perspective
Genomics and Healthcare A global and local perspective Kathryn North Director, Murdoch Childrens Research Institute Director, Victorian Clinical Genetics Service David Danks Professor of Child Health Research,
More informationNanthealth Patient Informed Consent
Patient Informed Consent Why am I being asked to give consent? You are being asked to sign this consent form because you want to have a molecular/genomic analysis performed to help your physician understand
More informationThe experience of Andalusia in ehealth and big data --- Big data in health - IMI s HARMONY project, European Parliament, Brussels, 19 June 2018
The experience of Andalusia in ehealth and big data --- Big data in health - IMI s HARMONY project, European Parliament, Brussels, 19 June 2018 Joaquín Dopazo Área de Bioinformática, Fundación Progreso
More informationLeveraging an Academic-Industry Partnership for Commercial Success
Leveraging an Academic-Industry Partnership for Commercial Success For 115 Years, the Nation s Leading Respiratory Hospital Respiratory Heritage: 115 Years of Respiratory Research and Care Allergy, Asthma,
More informationNATURE AND NURTURE: BABY S DEVELOPMENT IS AFFECTED BY GENES AND CONDITIONS IN THE WOMB
MEDIA RELEASE 28 APRIL 2014 NATURE AND NURTURE: BABY S DEVELOPMENT IS AFFECTED BY GENES AND CONDITIONS IN THE WOMB A*STAR-led international study provides new insights into the relationship between genes
More informationTransforming care for the future
Transforming care for the future Professor Sue Hill @CSOSue Chief Scientific Officer for England Date 2017 The National Health Service (NHS) in numbers Semi-integrated system providing care to 55 million
More informationVertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis
Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis -Collaboration to explore use of mrna Therapeutics to treat the underlying cause of CF
More information23andMe Research: By the People, For the People. Carrie Northover, PhD Manager, Research Partnerships Health Datapalooza 2016
23andMe Research: By the People, For the People Carrie Northover, PhD Manager, Research Partnerships Health Datapalooza 2016 What is 23andMe? Direct to consumer genetic testing company Customers receive
More information6th Form Open Day 15th July 2015
6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine
More informationBIOTECH IN FRANCE. key info in. points
BIOTECH IN FRANCE 10 key info in points 1 2 3 INSERM: EUROPE S #1 ACADEMIC BIOTECH RESEARCH INSTITUTE INSERM spearheads healthcare and medical research in France, filing more biotech patents with the European
More information-YOUR PARTNER IN RESEARCH AND DEVELOPMENT
-YOUR PARTNER IN RESEARCH AND DEVELOPMENT WHY CHOOSE NORWAY? A healthcare system with great opportunities for research....... 2 Unique and accessible health registries and biobanks........... 3 A great
More informationImproving Population Health One Person at a Time
Improving Population Health One Person at a Time Session #PH5, March 5, 2018 India Hook-Barnard, PhD Director, Research Strategy Associate Director, Precision Medicine 1 Conflict of Interest India Hook-Barnard,
More information2017 HTS-CSRS COMMUNITY PUBLIC WORKSHOP
2017 HTS-CSRS COMMUNITY PUBLIC WORKSHOP GenomeNext Overview Olympus Platform The Olympus Platform provides a continuous workflow and data management solution from the sequencing instrument through analysis,
More informationPersonalized Human Genome Sequencing
Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome
More informationShivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare
Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare The world of healthcare is changing - with two revolutionary technologies, genomics and blockchain poised to significantly
More informationWillem H Ouwehand FMedSci Professor of Experimental Haematology Director NIHR BioResource Rare Diseases
Willem H Ouwehand FMedSci Professor of Experimental Haematology Director NIHR BioResource Rare Diseases Did The Cambridge genomic revolution discoveries when and how will it impact on the NHS and thus
More informationPresentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development
Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International
More informationThe Wellcome Trust. Research Support and Strategy in Epidemiology. Monday, 22 September Dr Alan Doyle
The Wellcome Trust Research Support and Strategy in Epidemiology Monday, 22 September 2008 Dr Alan Doyle The Wellcome Trust an independent researchfunding charity established 1936 funded from private endowment
More informationBREXIT BRIEFING. Medical research. Maintaining an effective working relationship between the UK and the EU. British Medical Association bma.org.
BREXIT BRIEFING Medical research Maintaining an effective working relationship between the UK and the EU British Medical Association bma.org.uk 2 British Medical Association Medical research Key points
More informationData Warehouse Systems at the German Centers for Health Research (DZG)
Data Warehouse Systems at the German Centers for Health Research (DZG) Roland Eils 26.10.16 Roland Eils The German Centers for Health Research è Fighting major disease challenges è Translational Research,
More informationBiomarkers as an emerging growth area in Denmark
Biomarkers as an emerging growth area in Denmark International Conference on Perspectives in Precision Medicine, Copenhagen March 1, 2018 Kim Holmstrøm, PhD. Chairman of The Danish Biomarker Network R&D
More informationDr. Stephen Kingsmore a vision for transforming medicine with rapid genome sequencing
Dr. Stephen Kingsmore a vision for transforming medicine with rapid genome sequencing Dr. Stephen Kingsmore, MD, DSc, is the President and CEO of the Rady Pediatric Genomics and Systems Medicine Institute.
More informationNIHR at 10: Wessex. Professor Chris Whitty Chief Scientific Adviser Department of Health
NIHR at 10: Wessex Professor Chris Whitty Chief Scientific Adviser Department of Health Building on 10 remarkable years The extraordinary advances in health are based on evidence and science, properly
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISEASE/CONDITION POPULATION TRIAD Submitting laboratory: Cambridge RGC Approved: September 2012
More information